PRDM16 and neoplasm: As the non-malignant cells mixed across almost all donor samples, such as tMC or immune cells (Fig. 2B–D), we did not regress for donor differences; thus, donor-specific tumor cell clustering in KC1 and MEL1–MEL4 is likely the result of genomic aberrations and not an effect of batch variations.